On May 25, Congressman Andy Barr (R-KY) introduced the Horseracing Integrity Act of 2017 to the House of Representatives. In summary, the bill requires “a uniform anti-doping and medication control program to be developed and enforced by an independent Horseracing Anti-Doping and Medication Control Authority.”
While the American Quarter Horse Association strongly supports uniformity in the horse racing industry, it is unable to support the latest version of the newly introduced legislation.
“Of particular concern regarding this proposal is the elimination of all race-day medications, including Lasix, the use of which has been endorsed by several equine groups and the American Association of Equine Practitioners to help mitigate the occurrence of exercise induced pulmonary hemorrhage in racehorses,” said Craig Huffhines, AQHA executive vice president. “American Quarter Horse representation on the Authority and funding sources for the program are also among other areas of concern that we have regarding the legislation as currently proposed.”
AQHA is committed to the welfare of the racehorse and continues to work with international, national and state racing organizations and commissions to evaluate protocols to allow for uniform medication rules and deterrents of performance-enhancing drugs. In addition, the use of Lasix in AQHA shows is currently under review by the AQHA Animal Welfare Commission by request of the Executive Committee.
In recent months, AQHA worked with the Association of Racing Commissioners International to separate American Quarter Horse flat racing in its medication violation model rules to help eliminate the use of illegal performance-enhancing medications. The Association has also supported recent industry movements that include out-of-competition testing and hair testing.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2019 Paulick Report.